Thomas Cunningham, MD
Gynecology · Monterey, CANPI 1700812799
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.0%), education and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 63.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $23,786 and has fallen 94.2% since, to $1,386 in 2025. Among gynecology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $531.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$23K
- Intuitive Surgical$13K
- Heartflow, Inc.$150
- Boston Scientific$71
- Myriad Women's Health, Inc.$39
- Baxter Healthcare$24
- plus $49 from 3 others
What the payments were for
- Speaking & faculty fees$19,15053%
- Travel & lodging$6,84419%
- Food & beverage$1,8695%
- Education$8,25023%
- Other$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $23,068 |
| Intuitive Surgical | 23 | $12,736 |
| Heartflow, Inc. | 1 | $150 |
| Boston Scientific | 2 | $71 |
| Myriad Women's Health, Inc. | 2 | $39 |
| Baxter Healthcare | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Coloplast | 1 | $19 |
| Organon | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$20,461
- Da Vinci Surgical System$10,273
- DAVINCI XI$2,250
- FFRct$150
How this compares
$36,137 in reported general payments places this provider in the 95th percentile of 247 gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 204 | $13,933 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 44 | $3,669 |
| Solifenacin Succinate | 26 | $3,014 |
| Estradiol (Twice Weekly)Estradiol | 30 | $2,645 |
| YuvafemEstradiol | 11 | $1,912 |
| DottiEstradiol | 12 | $1,664 |
| ProgesteroneProgesterone, Micronized | 43 | $1,657 |
| Clobetasol Propionate | 23 | $818 |
| Raloxifene Hcl | 16 | $796 |
| Oxybutynin Chloride ErOxybutynin Chloride | 17 | $496 |
| Alendronate Sodium | 44 | $329 |
| ValacyclovirValacyclovir Hcl | 15 | $195 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $174 |
| Ibuprofen | 32 | $154 |
| Medroxyprogesterone Acetate | 13 | $150 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Monterey
- Bruce LeeMonterey$2.8M
- Barbara Levyla Jolla$719K
- Samar NahasRiverside$132K
- Aarathi CholkeriEl Segundo$128K
- Kelly WrightLos Angeles$119K
- Naphthali AlinsodLaguna Beach$108K
- Albertine OmaniOakland$70K
- Matthew SiedhoffBeverly Hills$67K
- Justin DiedrichAgoura Hills$46K
- Ricki PollycoveSan Francisco$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.